ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 55 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 2,000,000 | $15,240,000 | 3.97% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 45,910 | $350,000 | 0.19% |
| Interchange Capital Partners, LLC | 24,420 | $186,000 | 0.10% |
| GOODWIN DANIEL L | 20,000 | $152,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 39,006 | $297,000 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,399 | $643,000 | 0.01% |
| BLAIR WILLIAM & CO/IL | 34,766 | $265,000 | 0.00% |
| Hartford Financial Management Inc. | 598 | $5,000 | 0.00% |
| HAP Trading, LLC | 25,100 | $27,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,374 | $11,000 | 0.00% |